First Trust Alternative Opportunities Fund 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 5:32 pm Sale |
2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
First Trust Alternative Opportunities Fund | 0 0.000% |
-40,000 (Position Closed) |
Filing |
| 2023-02-14 12:26 pm Purchase |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
First Trust Alternative Opportunities Fund | 40,000 9.690% |
40,000 (New Position) |
Filing |